Moderna completes enrollment in large Covid-19 vaccine study – Times of India

NEW DELHI: Moderna Inc said on Thursday it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third of the participants from communities of color.
Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.
Moderna said its study includes more than 11,000 participants from minority communities, including 6,000 Hispanic or Latin-American participants and more than 3,000 Black or African-American participants.
The company said it would evaluate the study’s risks and benefits before submitting an emergency-use application for the vaccine to the US health regulator.
The US Food and Drug Administration requires at least two months of safety data after a full vaccination regime to review applications for emergency use authorization of an experimental vaccine.

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Comcast Just Said It’s Planning to Make Working From...

Figuring out how to work from home is challenging. It's hard enough figuring out...

LeBron James Reveals Key To Lakers Winning Championship

LeBron James revealed the key to the Lakers' quest...

A More Intelligent Approach To Capitalism

As loyal readers of this column will know, your correspondent views capitalism as the...

How Clay Dunn Is Fighting For Girls Around The...

Jessica Abo sat down with Clay Dunn. He is the CEO of VOW for...